Department of Psychiatry and Environmental Health Center, Dankook University, College of Medicine, Cheonan 330-715, Korea.
J Ginseng Res. 2011 Jun;35(2):226-34. doi: 10.5142/jgr.2011.35.2.226.
We investigated the clinical effects of Korean red ginseng on attention deficit hyperactivity disorder (ADHD) in children. Eighteen subjects aged between 6 and 14 diagnosed with ADHD based on the Diagnostic and Statistical Manual of Mental Disorders, fourth edition diagnosis criteria were enrolled. Korean red ginseng (Panax ginseng) at 1,000 mg b.i.d. was administered to the subjects for 8 weeks. Eighteen children completed the questionnaire and clinical assessment by visiting the hospital at baseline, then in the first, fourth and eighth weeks. Clinical assessments were performed by using the ADHD Diagnostic System (ADS, a computerized attention assessment program), the abbreviated Conners' rating scale in addition to psychiatric interviews. After 8 weeks, significant differences were found in the omisssion errors of ADS (78.56±43.33 at baseline, 55.17±21.44 at 8 weeks, p<0.023), Conners ADHD Rating Scale (13.78±6.32 at baseline, 9.50±4.80 at 8 weeks, p<0.042) and Spielberger State Anxiety Scale (30.94±6.25 at baseline, 28.83±6.23 at 8 weeks, p<0.024). In the Korean Personality Inventory for Children, a significant reduction of score was found in the physical development scale (56.44±9.63 at baseline, 50.94±8.91 at 8 weeks, p<0.017) and social dysfunction scale (56.33±6.82 at baseline, 51.94±7.13 at 8 weeks, p<0.025). These results suggest that Korean red ginseng may be effective in improving inattentiveness in ADHD children, but it remains uncertain if it improves the general severity of ADHD, depression, anxiety personality and behavioral changes.
我们研究了高丽红参对儿童注意缺陷多动障碍(ADHD)的临床疗效。18 名年龄在 6 至 14 岁之间的儿童,根据《精神障碍诊断与统计手册》第四版的诊断标准被诊断为 ADHD。给予这些儿童每日两次 1000 毫克的高丽红参(Panax ginseng),连续 8 周。18 名儿童在基线时、第 1 周、第 4 周和第 8 周到医院完成问卷和临床评估。临床评估采用 ADHD 诊断系统(ADS,一种计算机注意力评估程序)、简明康纳氏评定量表以及精神病访谈。经过 8 周,ADS 的遗漏错误(基线时 78.56±43.33,第 8 周 55.17±21.44,p<0.023)、康纳氏 ADHD 评定量表(基线时 13.78±6.32,第 8 周 9.50±4.80,p<0.042)和斯皮尔伯格状态焦虑量表(基线时 30.94±6.25,第 8 周 28.83±6.23,p<0.024)均有显著差异。在《儿童韩国人格量表》中,身体发育量表(基线时 56.44±9.63,第 8 周 50.94±8.91,p<0.017)和社会功能障碍量表(基线时 56.33±6.82,第 8 周 51.94±7.13,p<0.025)的评分显著降低。这些结果表明,高丽红参可能有助于改善 ADHD 儿童的注意力不集中,但尚不确定其是否能改善 ADHD 的总体严重程度、抑郁、焦虑、人格和行为变化。